Clin Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bell, D. S.H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bell, D. S.H.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Clinical Diabetes 22:61-65, 2004
© American Diabetes Association ®, Inc., 2004

Feature Article

Heart Failure: A Serious and Common Comorbidity of Diabetes

David S.H. Bell, MB, FACE

In Brief

Because of the cardiotoxic triad (diabetic cardiomyopathy, hypertension, and coronary artery disease), heart failure (HF) has an increased prevalence and worse prognosis in diabetic patients. Treatment of HF is directed to glycemic control and blockade of the renin-angiotensin and sympathetic nervous system, primarily with angiotensin-converting enzyme inhibitors and a combined {alpha}-/ß-blocker. The goal is preventing and reversing myocardial remodeling, which will improve ventricular function.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2004 by the American Diabetes Association.